{"id":"https://openalex.org/W1500156157","doi":"https://doi.org/10.1300/j069v19n02_03","title":"Methadone Dose and Retention During Treatment of Heroin Addicts with Axis I Psychiatric Comorbidity","display_name":"Methadone Dose and Retention During Treatment of Heroin Addicts with Axis I Psychiatric Comorbidity","alternate_titles":[],"publication_year":2000,"publication_date":"2000-04-04","ids":{"openalex":"https://openalex.org/W1500156157","doi":"https://doi.org/10.1300/j069v19n02_03","mag":"1500156157","pmid":"https://pubmed.ncbi.nlm.nih.gov/10809518"},"language":"en","primary_location":{"id":"doi:10.1300/j069v19n02_03","doi":"https://doi.org/10.1300/j069v19n02_03","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j069v19n02_03","pdf_url":null,"source":{"id":"https://openalex.org/S93508928","display_name":"Journal of Addictive Diseases","issn_l":"1055-0887","issn":["1055-0887","1545-0848"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addictive Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1500156157"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049381557","display_name":"Icro Maremmani","orcid":"https://orcid.org/0000-0002-6324-0576","observed_orcids":["https://orcid.org/0000-0002-6324-0576"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Icro Maremmani","raw_affiliation_strings":["Department of Psychiatry-Neurobiology-Pharmacology and Biotechnology, University of Pisa, Italy","Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology-Pharmacology and Biotechnology, University of Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry-Neurobiology-Pharmacology and Biotechnology, University of Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]},{"raw_affiliation_string":"Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology-Pharmacology and Biotechnology, University of Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003901063","display_name":"Orietta Zolesi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Orietta Zolesi","raw_affiliation_strings":["Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology- Pharmacology and Biotechnology, University of Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology- Pharmacology and Biotechnology, University of Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103429049","display_name":"Mirella Aglietti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mirella Aglietti","raw_affiliation_strings":["Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology- Pharmacology and Biotechnology, University of Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology- Pharmacology and Biotechnology, University of Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063376864","display_name":"Giada Marini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giada Marini","raw_affiliation_strings":["Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology- Pharmacology and Biotechnology, University of Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Addiction-Psychiatry Unit, Department of Psychiatry-Neurobiology- Pharmacology and Biotechnology, University of Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111569477","display_name":"Alessandro Tagliamonte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alessandro Tagliamonte","raw_affiliation_strings":["Institute of Nervous and Mental Diseases, University of Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Nervous and Mental Diseases, University of Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057823713","display_name":"Marc S. Shinderman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Shinderman","raw_affiliation_strings":["Center for Addictive Problems, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Addictive Problems, Chicago, IL, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112868554","display_name":"Sarz Maxwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarz Maxwell","raw_affiliation_strings":["Center for Addictive Problems, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Addictive Problems, Chicago, IL, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0349,"has_fulltext":false,"cited_by_count":78,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86408504,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"19","issue":"2","first_page":"29","last_page":"41"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.7720000147819519},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.8009999990463257},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9599999785423279},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dual-diagnosis","display_name":"dual diagnosis","score":0.8970000147819519},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.7480000257492065},{"id":"https://openalex.org/keywords/methadone-dose","display_name":"methadone dose","score":0.8090000152587891},{"id":"https://openalex.org/keywords/axis-i-psychiatric-disorders","display_name":"Axis I psychiatric disorders","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.8630487322807312},{"id":"https://openalex.org/C3018243667","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Psychiatric comorbidity","level":3,"score":0.8074384331703186},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.8035484552383423},{"id":"https://openalex.org/C2777955769","wikidata":"https://www.wikidata.org/wiki/Q2914812","display_name":"Dual diagnosis","level":3,"score":0.699447512626648},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.6839756965637207},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6158859133720398},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.580028235912323},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5363017320632935},{"id":"https://openalex.org/C2909052318","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Heroin addiction","level":4,"score":0.48580217361450195},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.45749104022979736},{"id":"https://openalex.org/C79736992","wikidata":"https://www.wikidata.org/wiki/Q7316676","display_name":"Retention rate","level":2,"score":0.42001569271087646},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41512852907180786},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.3051547408103943},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2570546567440033},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25422120094299316},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017831","descriptor_name":"Diagnosis, Dual (Psychiatry)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1300/j069v19n02_03","doi":"https://doi.org/10.1300/j069v19n02_03","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j069v19n02_03","pdf_url":null,"source":{"id":"https://openalex.org/S93508928","display_name":"Journal of Addictive Diseases","issn_l":"1055-0887","issn":["1055-0887","1545-0848"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addictive Diseases","raw_type":"journal-article"},{"id":"pmid:10809518","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10809518","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of addictive diseases","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W188764898","https://openalex.org/W611075468","https://openalex.org/W1493936182","https://openalex.org/W1508313796","https://openalex.org/W1541662928","https://openalex.org/W1543439003","https://openalex.org/W1778494765","https://openalex.org/W1973887879","https://openalex.org/W1990833214","https://openalex.org/W2011171069","https://openalex.org/W2017721530","https://openalex.org/W2031460352","https://openalex.org/W2045348212","https://openalex.org/W2070689175","https://openalex.org/W2101052953","https://openalex.org/W2105566914","https://openalex.org/W2106389903","https://openalex.org/W2107555396","https://openalex.org/W2159011576"],"related_works":["https://openalex.org/W2016976144","https://openalex.org/W28731703","https://openalex.org/W2002538759","https://openalex.org/W2057691104","https://openalex.org/W2113486096","https://openalex.org/W2003618910","https://openalex.org/W1971433460","https://openalex.org/W2121497098","https://openalex.org/W168236986"],"abstract_inverted_index":{"We":[0],"studied":[1],"90":[2],"opioid-dependent":[3],"subjects,":[4],"38":[5],"with":[6,16,49],"one":[7],"or":[8],"more":[9],"additional":[10],"Axis":[11,73],"I":[12,74],"diagnosis":[13,75],"and":[14],"52":[15],"no":[17,86],"psychiatric":[18,50],"comorbidity.":[19],"There":[20],"were":[21,85],"significant":[22],"differences":[23,87],"between":[24,88],"these":[25],"two":[26,90],"groups":[27,91],"regarding":[28],"the":[29,39,80,89],"methadone":[30,62],"dose":[31,56],"required":[32,52],"for":[33,69],"clinical":[34],"stabilization,":[35],"but":[36],"not":[37],"in":[38,43,94,98],"rate":[40],"of":[41,57,61,92,96],"retention":[42,97],"treatment.":[44,99],"Dual":[45],"Diagnosis":[46],"patients,":[47],"those":[48],"comorbidity,":[51],"an":[53],"average":[54],"stabilization":[55],"154":[58],"+/-":[59,66],"84":[60],"compared":[63],"to":[64],"99":[65],"49":[67],"mg/day":[68],"patients":[70,93],"whose":[71],"only":[72],"was":[76],"Opioid":[77],"Dependence.":[78],"In":[79],"990-day":[81],"period":[82],"considered":[83],"there":[84],"terms":[95]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1500156157","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
